Skip to content
JournalsWorldThe Global Research Discovery Platform
SCHOLARLY PUBLICATION ✓ Open Access

Clinical Pharmacogenetics Implementation Consortium Guideline for Thiopurine Dosing Based on TPMT and NUDT 15 Genotypes: 2018 Update

Mary V. Relling, Matthias Georg Schwab, Michelle Whirl‐Carrillo, Guilherme Suarez‐Kurtz, Ching‐Hon Pui, Charles Michael Stein, Ann M. Moyer, William Edward Evans, Teri E. Klein, Federico Antillón‐Klussmann, Kelly E. Caudle, Motohiro Kato, Allen Eng Juh Yeoh, Kjeld Schmiegelow, Jun J.J. Yang

📖 Clinical Pharmacology & Therapeutics 📅 2018-11-17 🔗 DOI: 10.1002/cpt.1304

📄 Abstract

Thiopurine methyltransferase (TPMT) activity exhibits a monogenic codominant inheritance and catabolizes thiopurines. TPMT variant alleles are associated with low enzyme activity and pronounced pharmacologic effects of thiopurines. Loss-of-function alleles in the NUDT15 gene are common in Asians and Hispanics and reduce the degradation of active thiopurine nucleotide metabolites, also predisposing to myelosuppression. We provide recommendations for adjusting starting doses of azathioprine, mercaptopurine, and thioguanine based on TPMT and NUDT15 genotypes (updates on www.cpicpgx.org).

📤 Share this page

Found this useful? Share it with your network.

✓ Link copied! Paste it on ResearchGate / Academia.edu